Boditech Media
-
PRESS RELEASE
Boditech Med has acquired export license for two Therapeutic Drug Monitoring (TDM) diagnostic kits
Expecting to increase the efficacy of the target drug and to reduce side effects with cost-effective system
-
PRESS RELEASE
Acquired approval for domestic use of ichroma™ IGRA-TB for Tuberculosis (TB) diagnosis from MFDS
Affordable and Accessible POC test for Latent TB diagnosis
-
PRESS RELEASE
Boditech Med launches two types of diagnostic kits essential for lifestyle diseases prevention
It takes only 5 mins to get a result
-
PRESS RELEASE
Boditech Med has received the export license of AFIAS Golimumab testing kit
It takes 10 mins to get test result with whole blood sample
-
PRESS RELEASE
Boditech Med signed MOU for CRISPR Cas system based diagnosis with nSAGE
It could be a new solution for POC Molecular diagnosis
-
PRESS RELEASE
Boditech Med acquired approval for domestic use of AFIAS COVID-19 antigen diagnostic kit from MFDS
It can detect delta variant and Lambda variant with high accuracy
-
PRESS RELEASE
Boditech Med has received the export license of AFIAS Adalimumab testing kit
It takes only 10 mins to get test result with whole blood sample
-
PRESS RELEASE
Announcing extension of production capacity
Increasing its production capacity two times comparing current capacity
-
PRESS RELEASE
Boditech Med acquires export license for COVID-19 neutralizing antibody diagnostic test
Enabling to diagnose the activity of neutralizing antibodies in 20 mins
-
PRESS RELEASE
Export licenses issued for two types of COVID-19 PCR test kits
Enabling accurate diagnosis by simultaneously detecting three specific genes of COVID-19 with only one sample